Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Takeda Pharmaceutical Li...

    OTC: TKPHF · Real-Time Price · USD
    29.45
    0.00 (0.00%)
    At close: Aug 13, 2025, 11:10 AM

    Takeda Pharmaceutical Balance Sheet Statement

    Financials in JPY. Fiscal year is April - March.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022 Mar 31, 2021
    Cash & Equivalents
    		 385.11B 457.8B 533.53B 849.7B 966.22B
    Short-Term Investments
    		 20.48B 15.09B 20.17B 25.3B 36.6B
    Long-Term Investments
    		 361.93B 430.61B 378.86B 330.13B 348.35B
    Other Long-Term Assets
    		 70.28B 51.21B 63.33B 82.61B 100.34B
    Receivables
    		 725.25B 697.61B 681.69B 724.38B 812.71B
    Inventory
    		 1,217.3B 1,209.9B 986.46B 853.17B 753.88B
    Other Current Assets
    		 173B 178.21B 302.54B 273.26B 285.3B
    Total Current Assets
    		 2,521.2B 2,558.6B 2,398B 2,593.6B 2,712.9B
    Property-Plant & Equipment
    		 1,968.2B 1,989.8B 1,691.2B 1,582.8B 1,453.9B
    Goodwill & Intangibles
    		 8,956B 9,684.7B 9,060.4B 8,226.3B 7,943B
    Total Long-Term Assets
    		 11,727.2B 12,550.2B 11,559.8B 10,584.4B 10,199.4B
    Total Assets
    		 14,248.3B 15,108.8B 13,957.8B 13,178B 12,912.3B
    Account Payables
    		 308.45B 319.95B 307.45B 295.93B 232.1B
    Deferred Revenue
    		 n/a n/a 740.74B 644.42B 616.48B
    Short-Term Debt
    		 548.94B 367.25B 339.6B 203.99B 22.15B
    Other Current Liabilities
    		 1,348.5B 1,559.7B 1,775.3B 1,591.9B 1,468.7B
    Total Current Liabilities
    		 2,506.5B 2,313.1B 2,481.9B 2,145.7B 1,773.2B
    Long-Term Debt
    		 3,966.3B 4,476.5B 4,042.7B 4,141.4B 4,613.2B
    Other Long-Term Liabilities
    		 804.37B 1,045.2B 450.55B 576.31B 731.2B
    Total Long-Term Liabilities
    		 4,805.8B 5,521.7B 5,121.1B 5,348.8B 5,961.9B
    Total Liabilities
    		 7,312.4B 7,834.8B 7,603.1B 7,494.5B 7,735.1B
    Total Debt
    		 4,515.3B 5,463.4B 4,382.3B 4,345.4B 4,635.4B
    Common Stock
    		 1,694.7B 1,676.6B 1,676.3B 1,676.3B 1,668.1B
    Retained Earnings
    		 1,187.6B 1,391.2B 1,541.1B 1,479.7B 1,509.9B
    Comprehensive Income
    		 2,351.9B n/a 1,508.1B 934.17B 366.11B
    Shareholders Equity
    		 6,935.1B 7,273.3B 6,354.1B 5,683B 5,173B
    Total Investments
    		 382.4B 445.7B 399.03B 355.44B 384.95B

    Add to Watchlist